AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding AIM ImmunoTech Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 38 | 33 | −5 |
| Shares | 4.15M | 4.09M | −59.8K (−1.4%) |
| Value | $1.83M | $1.93M | +$100.8K (+5.5%) |
New holders (2)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 21,420 | $10.1K | 0.00% |
| XTX Topco Ltd | 14,115 | $6.65K | 0.00% |
Sold out (7)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 34,018 | $15.0K |
| Bank of New York Mellon Corp | 25,268 | $11.1K |
| Jane Street Group, LLC | 21,257 | $9.35K |
| Virtu Financial LLC | 15,569 | $7.00K |
| SNS Financial Group, LLC | 10,000 | $4.40K |
| TD Waterhouse Canada Inc. | 170 | $107 |
| BNP Paribas Arbitrage, SA | 2 | $1 |